A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry
Nils Tore Vethe(Oslo University Hospital), Stein Bergan(Oslo University Hospital), Einar Husebye(Drammen Hospital), Anders Andersen(Oslo University Hospital), John Munkhaugen(University of Oslo)
Cited by 25
Related Papers
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis
|European Journal of Preventive Cardiology|2017|402
Prehypertension, Obesity, and Risk of Kidney Disease: 20-Year Follow-up of the HUNT I Study in Norway
|American Journal of Kidney Diseases|2009|156
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
|European Heart Journal - Cardiovascular Pharmacotherapy|2018|121
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
|New England Journal of Medicine|2025|73
Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway
|Nephrology Dialysis Transplantation|2009|67